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We have developed serum-free primary cultures of differentiated follicular dog thyroid cells which allow 
the study of the hormonal control of cell proliferation. The cooperation of insulin and increasing cellular 
cyclic AMP by thyrotropin triggers the DNA synthesis and the proliferation. Dog thyroid cells are an 
example of a system in which cyclic AMP is a sufficient signal to stimulate the proliferation in quiescent 
cells. 
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1. INTRODUCTION 
The possibility that cyclic AMP (CAMP) may 
regulate normal cell proliferation is the subject of 
a plethoric but controversial literature. From the 
first studies using mainly cultured fibroblasts, 
CAMP has been proposed as a universal in- 
tracellular negative signal for proliferation [l]. An 
objection to many of these studies has been that 
these effects were elicited by high concentrations 
of analogues of CAMP and could be regarded as 
non-specific [2,3]. Now CAMP has been shown to 
have a positive influence on the proliferation of a 
growing number of cultured cells from various 
origins, including hepatocytes [4-61 and 3T3 
fibroblasts [7], the systems in which the understan- 
ding of proliferation is the most advanced. The 
problem has a special interest in endocrine 
epithelial tissues in which activity and growth in 
vivo are specifically controlled by pituitary trophic 
hormones (ACTH, FSH, LH, TSH) whose main 
action is to stimulate adenylate cyclase. However, 
in general, these trophic hormones have rather in- 
hibitory effects on the proliferation of their target 
cells in culture [8-131, leading to the speculation 
that they may not be direct mitogens in vivo 
[I&12,13]. 
Little is known about hormonal effects on 
thyroid cell proliferation. In a few culture systems, 
thyrotrophin (TSH) stimulates DNA synthesis and 
proliferation [14-161, but not in several others 
[13,17,18]. In terms of mechanisms, dog thyroid 
cells in primary culture in monolayer remain a uni- 
que model as, in this sytem, the growth-promoting 
action of TSH has been shown to be reproduced by 
increasing intracellular CAMP levels [la]. How- 
ever, the interpretaion of our results and the 
characterization of the TSH effect have been 
limited by the fact that the serum-containing 
medium by itself promotes cell multiplication 
which is only enhanced by thyrotropin. Serum is a 
complex, variable, not fully characterized hor- 
monal mixture which may mask or affect the 
response of cells to purified hormones or factors 
[19]. Therefore, we describe here serum-free, 
defined culture conditions in which the differen- 
tiated naturally quiescent dog thyroid cells can be 
induced to synthesize DNA and to proliferate by 
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TSH acting via CAMP. The only hormone required 
to obtain the TSH effect on proliferation, is 
insulin. 
2. MATERIALS AND METHODS 
2.1. Materials 
Collagenase (150 U/mg) was purchased from 
Worthington Chemical Co. (Freehold NJ). 
Dulbecco’s modification of minimum essential 
medium (DMEM), Ham’s F12 medium, MCDB 
104 medium, glutamine, penicillin-streptomycin 
and amphotericin B (fungizone) were obtained 
from Flow Labs (Irvine). Bovine insulin and 
transferrin were purchased from Collaborative 
Research (Waltham MA). Glycyl-histidyl-lysyl 
acetate and somatostatin were Sigma products (St 
Louis MO). Bovine TSH (1 U/mg) was from Ar- 
mour Pharmaceutical Co. (Chicago IL) or, when 
purified (40 U/mg), was a generous gift of Dr 
Pierce (UCLA CA). Cholera toxin was provided 
by Schwarzmamr (Division of Decton-Dickinson, 
Orangeburg NY). Forskolin was from Hoechst 
Pharmaceuticals (Bombay), dibutyryl cyclic AMP 
(dbcAMP) from Boehringer Pharmaceutical 
(Mannheim) and RO 20-1724 was a gift of Hoff- 
man-La Roche (Nutley NJ). [methyC3H]Thy- 
midine (40 CVmmol) was from the Radiochemical 
Centre (Amersham). 
2.2. Cell culture 
The dog thyroid cells were cultured as in [16], 
but in a serum-free defined medium. Briefly, the 
thyroid tissue was digested by collagenase so that 
the resulting suspension consisted mainly of 
fragmented and intact follicles. These follicles 
were seeded in 35 mm tissue culture-treated plastic 
Petri dishes, and, in 1 day, adhered to the substrat- 
um while a monolayer developed. The seeding was 
realized so that 5 x 104-2 x lo5 cells attached to 
the dish after 1 day and 1 medium change. The 
cells were cultured in the following mixture which 
constitutes the control medium: DMEM + F12 + 
MCDB 104 (2 : 1: 1, by vol.) with 2 mM glutamine, 
supplemented by 10 yg insulin/ml, 1.25 pg trans- 
ferrin/ml, 10 ng glycyl-histidyl-lysyl-acetate/ml, 
10 ng somatostatin/ml and 40 ,ug ascorbic acid/ml. 
Antibiotics, penicillin 100 U/ml, streptomycin 
100 pg/ml and amphotericin B 2.5 /g/ml were also 
added. The Petri dishes were maintained in a 
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water-saturated incubator at 37°C in an atmos- 
phere of 5% CO2 in air. The medium was renewed 
and TSH or other effecters were added as indi- 
cated. 
2.3. Proliferation assays 
Cell multiplication curves were obtained from 
cell DNA measurements. Our cell DNA assay 
described in [16], uses the increase of fluorescence 
of ethidium bromide when complexed with nucleic 
acids. It has been verified that an increase in DNA 
quantity per dish reflected an increase in cell 
number [16]. 
DNA synthesis was estimated by the incorpora- 
tion of [3H]thymidine into 10% trichloroacetic 
acid-precipitable material or by the frequency of 
the [3H]thymidine-labelled nuclei as estimated by 
autoradiography. The cells in the Petri dishes were 
incubated for 24 h time-periods or for determined 
times after the addition of a proliferation stimul- 
ator, in the complete medium in which thymidine 
was increased to 3 x 10m5 M, supplemented with 
lob4 M deoxycytidine and 10&i t3H]thymi- 
dine/ml. The cells were stopped by 10% trichloro- 
acetic acid or, for autoradiography, fixed by 
methanol, and then extensively washed. Auto- 
radiographies were performed as in [20] directly in 
the Petri dishes. The cells were stained with 
toluidine blue (19’0) and the proportion of labelled 
nuclei was evaluated by counting at least 500 nuclei 
from different microscopical fields. Silver grains 
were exclusively restricted to the nuclei and, in 
some cases, it was observable that nucleoli remain- 
ed unlabelled. 
Results were expressed as means + ranges of 
measurements on duplicate Petri dishes. All results 
presented were confirmed in at least 3 independent 
cultures. 
3. RESULTS 
Plated directly on plastic tissue culture-treated 
Petri dishes in the serum-free defined medium, 
most intact or fragmented follicles very rapidly at- 
tached (about 50% in 15 min) and subsequently 
spread and developed a cell monolayer. Addition 
of TSH (lOaU-10 mu/ml) at any time after the 
formation of the monolayer, induced rapidly a 
conspicuous cytoplasmic arborization in the whole 
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cell population. This acute morphological effect of 
TSH is characteristic of the TSH-responsive epith- 
elial thyroid cells in monolayer [13,21,22]; it was 
reproduced by treatments we used to increase in- 
tracellular CAMP levels; i.e., by cholera toxin 
(20 ng/ml), forskolin (10m5 M) [23,24] or by 
dbcAMP (5 x lo-’ M) in the presence of the in- 
hibitor of phosphodiesterases RO 20-1724 (4 x 
lo-’ M). TSH and treatments increasing CAMP 
chronically stimulated our cells to actively concen- 
trate radioiodide (a thyroid-specific marker of dif- 
ferentiation) at very high levels (cell to medium 
ratios were currently above 100) (not shown). This 
suggests that the cultures used in this study were 
purely constituted of follicular thyroid cells which 
all responded to TSH in a CAMP-dependent fash- 
ion. 
3.1. Stimulation of proliferation by TSH 
As seen in fig. 1, in the absence of TSH, the cells 
were surviving and showed a little increase in DNA 
content per dish in the first days of culture. Addi- 
tion of TSH (1 mu/ml), 1 day after seeding and its 
continuous presence in the culture medium result- 
ed in a limited but significant proliferation. 
The study of DNA synthesis by incorporation of 
24 h pulses of [3H]thymidine into 10% trichloro- 
acetic acid-precipitable material is shown in fig.2. 
In control medium, the cells weakly incorporated 
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Fig.1. Stimulation of proliferation by TSH in defined 
conditions. The cells were seeded as in section 2. TSH 
(1 mu/ml) was added to control medium at day 1 and 
its presence was maintained throughout he culture 
period, while medium was renewed every other day. 
TSH ‘-, 
CONTROL 
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Fig.2. DNA synthesis by thyroid cells in response to 
TSH. The cells were seeded and cultured in the control 
medium as in section 2. At day 4, TSH (1 mu/ml) was 
added to some dishes and its presence was maintained 
for the rest of the culture period. The medium was 
renewed every day. [3H]Thymidine (lOpCi/ml, 3 x 
10m5 M) incorporation i  the presence of deoxycytidine 
(10e4 M) into acid-insoluble material was determined 
for 24 h periods and normalized to the quantity of cell 
DNA/dish. 
thymidine in the first days following initiation of 
cultures. After day 4, virtually no incorporation 
was observed, the cells remaining quiescent. There 
was no concomitant decrease of the DNA content 
which suggests that no significant cell death occur- 
red in our serum-free cultures, at least until day 8. 
Addition of TSH (1 mu/ml) at day 4 (i.e., to sta- 
tionary cells) triggered, 24 h thereafter, a burst of 
thymidine incorporation (about 50 x increase) 
which decreased uring the following days. 
Autoradiography of [3H]thymidine labelled nu- 
clei 24 h after addition of TSH (1 mu/ml) (fig.3). 
There was therefore a 24 h time lag after TSH ad- 
dition. 60 h after TSH addition, a majority of cells 
were labelled. Labelling was randomly distributed 
in the follicle-derived colonies, but the colonies 
were not all equally labelled. Mitoses and sub- 
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Fig.3. A~umulation of t3~~th~~ne-la~~~ nuclei 
after addition of TSH. The cells were cultured for 4 days 
in control medium with one medium change at day 2. 
TSH (1 mu/ml) was added at day 4 (0 h) and its 
presence maintained for the rest of the experiment while 
the medium was still changed at day 5. [3H]Thymidine 
was present from 0 h until the times indicated. At the 
indicated times, the cells were fiied in methanol, rinsed 
and processed for autoradiography. The fraction of 
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Table 1 
Effect of TSH and treatments increasing CAMP on 
t3H]th~idine incorporation in the DNA of dog thyroid 
cells 
cpm/ng Vo labelled 
DNA nuclei 
Expt I 
Control 1.28 f 0.29 1.9 f 0.5 
TSH (1 mU/ml) 24.0 &to,2 53.2 f 4.5 
Pure TSH (25 n&ml) 18.6 f 1.2 59.8 f 4.3 
dbcAMP (5. lo-‘) 
+ Ro 20-1724 (4. IO-’ M) n.d. 44.3 k 8.1 
Cholera toxin (10 ng/ml) 28.9 it 1.9 52.6 i 5.9 
Expt II 
Control 1.78 f 0.21 n.d. 
TSH (1 mU/ml) 19.7 f 2.3 n.d. 
Forskolin (IO-’ M) 19.1 f 2.5 n.d. 
n.d. = not dete~in~ 
The experiments were performed as in fig.2 and 3. TSH 
or the other effecters were added at day 4. [‘H]Thym- 
idine incorporation was for 24 h between days 5 and 6. 
DNA synthesis was estimated by the incorporation of 
radioactivity into acid-insoluble material, normahzed to 
ceII DNA, or by the fraction of label&l nuclei revealed 
by autoradiography 
sequent divisions of labelled cells were observed. 
Concentration-action curves of TSH added at day 
4 on the thymidine incorporation and on DNA ac- 
cumulation were similar. The effects were observ- 
ed at 50,uU/ml, half-maximal at lOO,&J/ml and 
maximal at 1 mu/ml. The maximal effects were 
similar whether crude bovine TSH preparation 
(-1 U/mg) or pure bovine TSH (40 Wmg) was 
used (table 1). 
Fig.4. Effect of TSH on the proIiferation of cells 
cultured in presence or in absence of insulin. The cells 
were seeded in the controt medium where insulin was 
omitted. At day 1, TSH (1 mu/ml) was added in 
presence or in absence of insulin (10 &ml). The 
presence of both hormones was maintained for the rest 
of the culture period while the medium was renewed 
every other day. 
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Table 2 
Effect of TSH on [‘Hlthymidine incorporation into 
DNA in the presence or in the absence of insulin 
070 labelled nuclei 
Insulin (10 tg/ml) 2.83 f 1.0 
TSH (1 mu/ml) 3.31 f 1.06 
TSH + insulin 33.5 f 4.7 
The cells were seeded and cultured for 2 days in control 
medium lacking insulin. At day 2, insulin (10 /rg/ml) was 
added to some dishes, and its presence maintained for 
the rest of the experiment. At day 4, TSH (1 mu/ml) 
was added to cells cultured with or without insulin, and 
its presence maintained for the rest of the culture. DNA 
synthesis was evaluated by incorporation of [‘Hlthyrn- 
idine for 24 h between day 5 and day 6, into nuclei and 
revealed by autoradiography 
3.2. Stimulation of proliferation by CAMP 
TSH acutely and chronically increases cellular 
CAMP levels in dog thyroid cells cultured in 
monolayer [16,25]. As seen in table 1, the maximal 
TSH effect on the initiation of DNA synthesis was 
quantitatively reproduced by treatments which ac- 
tivate adenylate cyclase and increase cellular 
CAMP levels; i.e., by the universal specific ac- 
tivators of adenylate cyclase, cholera toxin [26] 
and the diterpene forskolin [27]. The effect of TSH 
was also reproduced by dbcAMP (5 x 10v5 M) in 
the presence of Ro 20-1724 (4 x lo-’ M), an in- 
hibitor of cyclic nucleotide phosphodiesterases. 
3.3. Importance of insulin in the stimulation of 
proliferation 
In our defined control medium, the only hor- 
mone which has a recognized role in the control of 
cell proliferation, is insulin 1281. Fig.4 shows that, 
in thyroid cells surviving in absence of insulin, 
TSH failed to increase the DNA quantity per dish, 
and did not trigger a significant DNA synthesis 
(table 2). 
4. DISCUSSION 
The present study describes for the first time 
completely defined serum-free culture conditions 
which allow the investigation of the hormonal con- 
trol of proliferation of normal differentiated 
thyroid cells in primary culture. The defined 
medium supports cell adherence and spreading, 
differentiation evaluated by the capacity of cells to 
trap iodide and to respond to TSH, and the 
stimulation of multiplication in quiescent cells. We 
use relatively short term primary cultures of cells 
which have not, in their majority, proliferated in 
vitro before hormone addition. These cells may 
not be suspected to be genetically transformed or 
selected by their in vitro culture conditions, as in 
the case of cloned cell lines. Fibroblast-like cells 
were never seen in our cultures. Possibly the few 
fibroblasts seeded with follicles could not attach to 
a plastic substratum in absence of serum. 
Under these conditions, we demonstrate that 
TSH triggers the synthesis of DNA and prolifera- 
tion in quiescent follicular canine thyroid cells. 
This effect is direct, requires neither the presence 
of other thyroid cell types, nor unidentified serum 
factors, nor the action of the purified hormone- 
like growth factors (epidermal and fibroblast 
growth factors). Such growth factors also stimul- 
ate the proliferation of canine thyroid cells [29] (in 
preparation). The TSH effect was obtained in the 
range of plasma TSH concentrations which cause 
the thyroid hyperplasia in vivo. 
Insulin is the only hormone which must be pre- 
sent in the culture medium to obtain the effect of 
TSH on proliferation. The two hormones work in 
synergy, cooperate to finally induce DNA syn- 
thesis and proliferation. Insulin is a general 
mitogenic factor for cultured cells. Its action may 
represent an anabolic permissive effect. However, 
at high concentrations, insulin acts as a weak 
analogue of the more specific mitogens the 
somatomedins [28]. We are currently investigating 
the respective roles of insulin and TSH in their 
synergistic stimulation of thyroid cell prolifera- 
tion. We have preliminary indications that insulin 
exerts part of its effects at low concentrations, sug- 
gesting an action via its high affinity receptors 
(unpublished). 
The main primary action of TSH on canine 
thyroid tissue [30] or on thyroid cells in culture 
116,251 is to activate adenylate cyclase and to in- 
crease cellular CAMP levels. TSH exerts most of its 
acute and delayed functional effects on dog 
thyroid via CAMP [31]. The fact that universal 
specific activators of adenylate cyclase (cholera 
toxin and forskolin) and a rather low concentra- 
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tion of the hydrophobic analogue of CAMP, 
dbcAMP, in presence of an inhibitor of phospho- 
diesterases, completely reproduced the mitogenic 
effect of TSH, demonstrates that TSH exerts also 
its effect on proliferation via CAMP as intra- 
cellular secondary signal. TSH also exerts CAMP- 
independent effects, including an increase in phos- 
phatidylinositol turnover and in Ca” transloca- 
tion [30]. The final significance of these effects re- 
mains unknown. However, as most growth factors 
have such effects and as Ca’+ is considered to have 
a key role in the control of proliferation [4,32], it 
was possible that such mechanisms may have a role 
in the control of thyroid cell proliferation by TSH. 
Our findings that the TSH effect on proliferation 
may be completely reproduced by agents which 
specifically increase CAMP levels, does not support 
this hypothesis, at least in the case of the dog 
thyroid. A rat thyroid cell line (FRTL) requires 
TSH and insulin in order to proliferate in a low- 
serum-hormone-supplemented medium [ 151, sim- 
ilarly to observations presented here. IN FRTLS, a 
cloned cell line derived from FRTL and adapted to 
grow in presence of 5% serum, dbcAMP does not 
reproduce the mitogenic effect of TSH [33] leading 
to the conclusion that TSH stimulates thyroid cell 
proliferation acting at least in part by CAMP-in- 
dependent mechanisms. Obviously, such negative 
evidence needs to be confirmed with more potent 
and specific stimulations of the cyclic AMP 
system. This apparent discrepancy may be due to 
species differences, but the possibility that cells, as 
FRTLS, continuously propagated and cloned in 
presence of TSH, became dependent of CAMP- 
independent TSH effects not originally involved in 
the growth control, may certainly not be ruled out. 
Many reports now suggest a positive influence of 
CAMP on the proliferation of cultured cells from 
a variety of tissues and species [4-7,12,34-421. In 
general, in these systems, cholera toxin or CAMP 
derivatives increase the proliferation stimulated by 
serum or growth factors [4-6,12,34-39,421. Like 
Swiss 3T3 fibroblasts [7], the dog thyroid cells 
cultured in defined conditions constitute a rare ex- 
ample of a model system in which an increase in 
cellular CAMP is sufficient to trigger the prolifera- 
tion of a significant part of a quiescent cell popula- 
tion. This system is therefore a very useful model 
for the biochemical investigation of the molecular 
events involved in the control of growth by CAMP. 
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